PURE SLEEP
DEAD

Serial Number

87832569

Owner

Pure Green

Attorney

Timothy C. Bradley

First Use Date

Feb 1, 2018

Filing Date

Mar 13, 2018

Add to watchlist:

No watchlists yet
View on USPTO

PURE SLEEP Trademark

Serial Number: 87832569 • Registration: 5605676

PURE SLEEP is a trademark filed by Pure Green on March 13, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Pure Green (4 trademarks)

4761 Tara Court
W. bloomfield, MI 48323

Entity Type: 16

Trademark Details

Filing Date

March 13, 2018

Registration Date

November 13, 2018

First Use Anywhere

February 1, 2018

First Use in Commerce

February 1, 2018

Published for Opposition

August 28, 2018

Cancellation Date

May 23, 2025

Goods & Services

Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical preparation for skin care; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for reducing sexual activity; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention of insomnia; Pharmaceutical preparations for the treatment and prevention of insomnia; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of insomnia; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, elixirs for the treatment of insomnia; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical skin lotions; Pharmaceutical solutions used in dialysis; Pharmaceuticals, namely, psychotropics; Analeptics; Anti-epileptic pharmaceutical preparations; Balms for pharmaceutical purposes; Bandages impregnated with sleep medication; Chemical preparations for pharmaceutical or medical purposes, namely, for sleep; Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of sleep agents that facilitate the delivery of pharmaceutical preparations; Plant extracts for medical, veterinary and pharmaceutical purposes; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Therapeutic pharmaceutical for the treatment of insomnia; Unit dose capsules sold empty for pharmaceutical use; Veterinary pharmaceutical preparations for the prevention of insomnia; Veterinary pharmaceutical preparations for the treatment of insomnia

Polyvinyl alcohol soluble films for use in the manufacture of delivery agents for pharmaceuticals, breath freshener, vitamins, and candy

Filing History

CANCELLED SEC. 8 (6-YR)
May 23, 2025 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Nov 13, 2023 REM1
REGISTERED-PRINCIPAL REGISTER
Nov 13, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 28, 2018 NPUB
PUBLISHED FOR OPPOSITION
Aug 28, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 8, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 15, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 27, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 26, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 26, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 25, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jun 25, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jun 25, 2018 CNRT
ASSIGNED TO EXAMINER
Jun 23, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 20, 2018 NWOS
NEW APPLICATION ENTERED
Mar 16, 2018 NWAP